ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2010 | 8.67 Million USD | 81.79% |
| 2009 | 4.77 Million USD | 11427.16% |
| 2008 | -42.13 Thousand USD | -213.09% |
| 2007 | 37.25 Thousand USD | 1083.28% |
| 2006 | -3789.14 USD | -121.85% |
| 2005 | 17.34 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2011 Q1 | 2.4 Million USD | -13.59% |
| 2011 Q3 | 1.74 Million USD | -28.29% |
| 2011 Q2 | 2.43 Million USD | 1.48% |
| 2010 Q4 | 2.77 Million USD | 45.26% |
| 2010 Q3 | 1.91 Million USD | -18.61% |
| 2010 FY | 8.67 Million USD | 81.79% |
| 2010 Q1 | 1.63 Million USD | -39.38% |
| 2010 Q2 | 2.34 Million USD | 43.51% |
| 2009 FY | 4.77 Million USD | 11427.16% |
| 2009 Q4 | 2.7 Million USD | 217.75% |
| 2009 Q3 | 849.97 Thousand USD | 1447.06% |
| 2009 Q1 | -14.48 Thousand USD | -189.45% |
| 2009 Q2 | -63.09 Thousand USD | -335.55% |
| 2008 Q1 | -6097.00 USD | -112.72% |
| 2008 FY | -42.13 Thousand USD | -213.09% |
| 2008 Q4 | 16.19 Thousand USD | 145.83% |
| 2008 Q2 | -21.52 Thousand USD | -252.96% |
| 2008 Q3 | -35.33 Thousand USD | -64.21% |
| 2007 FY | 37.25 Thousand USD | 1083.28% |
| 2007 Q4 | 47.94 Thousand USD | 66.55% |
| 2007 Q1 | -34.89 Thousand USD | -1278.36% |
| 2007 Q3 | 28.78 Thousand USD | 729.87% |
| 2007 Q2 | -4570.00 USD | 86.9% |
| 2006 Q1 | 2278.01 USD | 0.0% |
| 2006 Q2 | -6877.68 USD | -401.92% |
| 2006 Q3 | 3342.42 USD | 148.6% |
| 2006 Q4 | -2531.89 USD | -175.75% |
| 2006 FY | -3789.14 USD | -121.85% |
| 2005 FY | 17.34 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 749.724% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 224.256% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 83.623% |
| Nascent Biotech, Inc. | -2.08 Million USD | 515.61% |
| Rebus Holdings, Inc. | -1.02 Million USD | 950.648% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 86.679% |
| Qrons Inc. | -789.34 Thousand USD | 1199.214% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 1471.998% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 113.861% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 2188.339% |
| Skye Bioscience, Inc. | -37.64 Million USD | 123.049% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 111.575% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 231.941% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | 3273.573% |
| SQZ Biotechnologies Company | -79.46 Million USD | 110.919% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 399.98% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 576.599% |
| Mesoblast Limited | -87.95 Million USD | 109.865% |
| Marizyme, Inc. | -65.34 Million USD | 113.278% |
| Genus plc | 7.9 Million USD | -9.831% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 179.662% |
| Pharming Group N.V. | -10.54 Million USD | 182.258% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 499.878% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 333.856% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 198.107% |
| ContraFect Corporation | -65.15 Million USD | 113.317% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 277.579% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 602.277% |
| IMV Inc. | -36.48 Million USD | 123.781% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 207.655% |
| MultiCell Technologies, Inc. | -380.07 USD | 2282998.413% |
| Accustem Sciences Inc. | -3.74 Million USD | 331.597% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 116.785% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | 784.743% |
| Q BioMed Inc. | -2.05 Million USD | 522.818% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 332.43% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 464.43% |
| Biomind Labs Inc. | -1.21 Million USD | 814.525% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 114.528% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 379.731% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 209.788% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 545.126% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | 58036.779% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 154.668% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 249.153% |
| GB Sciences, Inc. | -1.36 Million USD | 737.2% |
| Alpha Cognition Inc. | -13.77 Million USD | 162.999% |
| HST Global, Inc. | -146.21 Thousand USD | 6034.349% |
| CSL Limited | 2.64 Billion USD | 99.672% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 594.458% |
| Halberd Corporation | -79.67 Thousand USD | 10989.869% |
| Enzolytics Inc. | -2.17 Million USD | 498.589% |
| Agentix Corp. | -1.37 Million USD | 731.389% |
| Resverlogix Corp. | -3.61 Million USD | 340.349% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 373.586% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -295.05 Million USD | 102.941% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | -8753.686% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | -25.301% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 318.39% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 386.723% |
| AVAX Technologies, Inc. | -6.41 Million USD | 235.284% |
| Zenith Capital Corp. | -10.59 Million USD | 181.886% |
| Genscript Biotech Corporation | -95.47 Million USD | 109.088% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | 37431.607% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 309.28% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | 14455.6% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 532.724% |
| Kadimastem Ltd | -3.3 Million USD | 362.34% |
| Helix BioMedix, Inc. | -1.05 Million USD | 921.605% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 327.196% |
| BioStem Technologies, Inc. | -8.48 Million USD | 202.283% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | 2065.841% |
| LadRx Corporation | 400.44 Thousand USD | -2066.753% |
| Cell Source, Inc. | -5.32 Million USD | 263.057% |
| Regen BioPharma, Inc. | 1.02 Million USD | -747.733% |
| Regen BioPharma, Inc. | 1.02 Million USD | -747.733% |
| NovAccess Global Inc. | -4.76 Million USD | 281.931% |
| Affymax, Inc. | -14.42 Million USD | 160.154% |
| Itoco Inc. | -1.86 Million USD | 564.239% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 295.308% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 619.869% |
| Mobile Lads Corp. | -2.26 Million USD | 483.362% |
| CytoDyn Inc. | -49.84 Million USD | 117.409% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | 11078.467% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | 3903.413% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | 1021.545% |
| SYBLEU INC | -180.3 Thousand USD | 4912.213% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | 638.005% |
| International Stem Cell Corporation | -131 Thousand USD | 6723.368% |
| Bioxytran, Inc. | -4.28 Million USD | 302.724% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | 16087.272% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 442.916% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 118.049% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 510.436% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -780.88 Thousand USD | 1211.123% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 373.883% |
| Neutra Corp. | -233.46 Thousand USD | 3816.451% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 142.761% |
| PureTech Health plc | -65.69 Million USD | 113.207% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 140.799% |
| IXICO plc | -1.17 Million USD | 836.554% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 187.404% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 115.188% |
| CSL Limited | 2.64 Billion USD | 99.672% |
| Cellectis S.A. | -103.17 Million USD | 108.41% |